Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia
- DOI
- 10.1111/dom.16221
- Published
- 2025-02-03
- Container
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/dom.16221,
title = {Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia},
author = {Kaori Ikeda and Fumika Mano‐Usui and Yo Kishimoto and Daisuke Yabe and Nobuya Inagaki and Koichi Omori and Yoji Nagai},
year = {2025},
journal = {Diabetes, Obesity and Metabolism},
doi = {10.1111/dom.16221},
url = {https://doi.org/10.1111/dom.16221}
}RIS
TY - JOUR TI - Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia AU - Kaori Ikeda AU - Fumika Mano‐Usui AU - Yo Kishimoto AU - Daisuke Yabe AU - Nobuya Inagaki AU - Koichi Omori AU - Yoji Nagai PY - 2025 JO - Diabetes, Obesity and Metabolism DO - 10.1111/dom.16221 UR - https://doi.org/10.1111/dom.16221 ER -
APA
Ikeda, K., Mano‐Usui, F., Kishimoto, Y., Yabe, D., Inagaki, N., Omori, K., & Nagai, Y. (2025). Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16221
Source records
- crossref · retrieved 2026-09-25T14:05:06.434Z